BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32112487)

  • 21. Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia.
    Alshammari TK; Alshammari MA; Nenov MN; Hoxha E; Cambiaghi M; Marcinno A; James TF; Singh P; Labate D; Li J; Meltzer HY; Sacchetti B; Tempia F; Laezza F
    Transl Psychiatry; 2016 May; 6(5):e806. PubMed ID: 27163207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular FGF14 (iFGF14) Is Required for Spontaneous and Evoked Firing in Cerebellar Purkinje Neurons and for Motor Coordination and Balance.
    Bosch MK; Carrasquillo Y; Ransdell JL; Kanakamedala A; Ornitz DM; Nerbonne JM
    J Neurosci; 2015 Apr; 35(17):6752-69. PubMed ID: 25926453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spinocerebellar ataxia-27: description of the clinical phenotype of two twin sisters with a deletion in the FGF14 gene].
    Blanco-Barca Ó; Amado-Puentes A; Repáraz A; Melcón C; Torreira C
    Rev Neurol; 2016 Mar; 62(5):238-9. PubMed ID: 26916329
    [No Abstract]   [Full Text] [Related]  

  • 24. FGF14 regulates presynaptic Ca2+ channels and synaptic transmission.
    Yan H; Pablo JL; Pitt GS
    Cell Rep; 2013 Jul; 4(1):66-75. PubMed ID: 23831029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan.
    Ando M; Higuchi Y; Yuan J; Yoshimura A; Kojima F; Yamanishi Y; Aso Y; Izumi K; Imada M; Maki Y; Nakagawa H; Hobara T; Noguchi Y; Takei J; Hiramatsu Y; Nozuma S; Sakiyama Y; Hashiguchi A; Matsuura E; Okamoto Y; Takashima H
    Ann Clin Transl Neurol; 2024 Jan; 11(1):96-104. PubMed ID: 37916889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autosomal dominant cerebellar ataxia type I: a review of the phenotypic and genotypic characteristics.
    Whaley NR; Fujioka S; Wszolek ZK
    Orphanet J Rare Dis; 2011 May; 6():33. PubMed ID: 21619691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural History and Phenotypic Spectrum of GAA-FGF14 Sporadic Late-Onset Cerebellar Ataxia (SCA27B).
    Wirth T; Clément G; Delvallée C; Bonnet C; Bogdan T; Iosif A; Schalk A; Chanson JB; Pellerin D; Brais B; Roth V; Wandzel M; Fleury MC; Piton A; Calmels N; Namer IJ; Kremer S; Tranchant C; Renaud M; Anheim M
    Mov Disord; 2023 Oct; 38(10):1950-1956. PubMed ID: 37470282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetazolamide-Responsive Episodic Ataxia Linked to Novel Splice Site Variant in FGF14 Gene.
    Schesny M; Joncourt F; Tarnutzer AA
    Cerebellum; 2019 Jun; 18(3):649-653. PubMed ID: 30607796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected].
    van Swieten JC; Brusse E; de Graaf BM; Krieger E; van de Graaf R; de Koning I; Maat-Kievit A; Leegwater P; Dooijes D; Oostra BA; Heutink P
    Am J Hum Genet; 2003 Jan; 72(1):191-9. PubMed ID: 12489043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pearls & Oy-sters: ATX-FGF14 Mimicking Autoimmune Pathology.
    Hoshina Y; Wright MA; Warner JEA; Richards T; Salzman KL; Pulst SM; Spoth E; Clardy SL
    Neurology; 2023 Oct; 101(14):e1478-e1482. PubMed ID: 37460234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central phenotype and related varieties of spinocerebellar ataxia 2 (SCA2): a clinical and genetic study with a pedigree in the Japanese.
    Sasaki H; Fukazawa T; Wakisaka A; Hamada K; Hamada T; Koyama T; Tsuji S; Tashiro K
    J Neurol Sci; 1996 Dec; 144(1-2):176-81. PubMed ID: 8994121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17.
    Brockmann K; Reimold M; Globas C; Hauser TK; Walter U; Machulla HJ; Rolfs A; Schöls L
    J Nucl Med; 2012 Jul; 53(7):1074-80. PubMed ID: 22653791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions.
    Gilman S; Sima AA; Junck L; Kluin KJ; Koeppe RA; Lohman ME; Little R
    Ann Neurol; 1996 Feb; 39(2):241-55. PubMed ID: 8967756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers.
    Tondo G; Mazzini L; Caminiti SP; Sarnelli MF; Corrado L; Matheoud R; D'Alfonso S; Cantello R; Sacchetti GM; Perani D; Comi C; De Marchi F
    Neuroimage Clin; 2022; 36():103222. PubMed ID: 36223668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
    Lyoo CH; Jeong Y; Ryu YH; Lee SY; Song TJ; Lee JH; Rinne JO; Lee MS
    Brain; 2008 Feb; 131(Pt 2):438-46. PubMed ID: 18178568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autosomal dominant congenital non-progressive ataxia overlaps with the SCA15 locus.
    Dudding TE; Friend K; Schofield PW; Lee S; Wilkinson IA; Richards RI
    Neurology; 2004 Dec; 63(12):2288-92. PubMed ID: 15623688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological and neuroimaging phenotype induced by a CAMTA1 mutation.
    Magnin E; Blagosklonov O; Sylvestre G; Minot D; Thevenon J; Faivre L; Boulahdour H; Thauvin-Robinet C; Rumbach L
    Brain Dev; 2014 Sep; 36(8):711-5. PubMed ID: 24145135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Male gender is associated with greater cerebral hypometabolism in frontotemporal dementia: evidence for sex-related cognitive reserve.
    Perneczky R; Diehl-Schmid J; Förstl H; Drzezga A; Kurz A
    Int J Geriatr Psychiatry; 2007 Nov; 22(11):1135-40. PubMed ID: 17479980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spinocerebellar ataxia 48 presenting with ataxia associated with cognitive, psychiatric, and extrapyramidal features: A report of two Italian families.
    De Michele G; Lieto M; Galatolo D; Salvatore E; Cocozza S; Barghigiani M; Tessa A; Baldacci J; Pappatà S; Filla A; De Michele G; Santorelli FM
    Parkinsonism Relat Disord; 2019 Aug; 65():91-96. PubMed ID: 31126790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain positron emission tomography in patients with myotonic dystrophy type 1 and type 2.
    Peric S; Brajkovic L; Belanovic B; Ilic V; Salak-Djokic B; Basta I; Rakocevic Stojanovic V
    J Neurol Sci; 2017 Jul; 378():187-192. PubMed ID: 28566162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.